Alaunos Therapeutics, Inc. (TCRT)
Data as of , from SEC Form 4 filings.
See up to 3 months of TCRT. The 7-day demo opens the 1M and 3M ranges and puts TCRT on your watchlist.
Start 7-day demoLatest TCRT insider trades
About Alaunos Therapeutics, Inc. (TCRT)
Alaunos Therapeutics, Inc. files with the SEC under CIK 0001107421 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
TCRT Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 9 | 123,373 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
TCRT insider transactions (Form 4)
3635 Form 4 filings on record, the earliest from Mar 29, 2025, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Grant or award | Common Stock | 23,564 footnote F1 | $0.74 | $18K | ||
| ||||||
| Jaime Vieser - Director | Grant or award | Common Stock | 22,669 footnote F1 | $0.74 | $17K | |
| ||||||
| Robert W. Postma - Director | Grant or award | Common Stock | 21,829 footnote F1 | $0.74 | $16K | |
| ||||||
| Michael Allen Jerman - Director | Grant or award | Common Stock | 20,990 footnote F1 | $0.74 | $16K | |
| ||||||
| Grant or award | Common Stock | 4,363 footnote F1 | $2.01 | $9K | ||
| ||||||
| Michael Allen Jerman - Director | Grant or award | Common Stock | 8,138 footnote F1 | $1.92 | $16K | |
| ||||||
| Grant or award | Common Stock | 4,568 footnote F1 | $1.92 | $9K | ||
| ||||||
| Robert W. Postma - Director | Grant or award | Common Stock | 8,463 footnote F1 | $1.92 | $16K | |
| ||||||
| Jaime Vieser - Director | Grant or award | Common Stock | 8,789 footnote F1 | $1.92 | $17K | |
| ||||||
| Grant or award | Common Stock | 3,880 footnote F1 | $2.26 | $9K | ||
| ||||||
| Grant or award | Common Stock | 7,761 footnote F1 | $2.26 | $18K | ||
| ||||||
| Grant or award | Common Stock | 3,700 footnote F1 | $2.37 | $9K | ||
| ||||||
| Jaime Vieser | Grant or award | Common Stock | 6,515 | $2.59 | $17K | |
| Robert W. Postma | Grant or award | Common Stock | 6,274 footnote F1 | $2.59 | $16K | |
| ||||||
| Michael Allen Jerman | Grant or award | Common Stock | 6,032 footnote F1 | $2.59 | $16K | |
| ||||||
| Michael Allen Jerman | Grant or award | Common Stock | 5,406 footnote F1 | $2.89 | $16K | |
| ||||||
| Robert W. Postma | Grant or award | Common Stock | 5,622 footnote F1 | $2.89 | $16K | |
| ||||||
| Jaime Vieser | Grant or award | Common Stock | 5,839 | $2.89 | $17K | |
| Jaime Vieser | Grant or award | Common Stock | 5,340 footnote F1 | $3.16 | $17K | |
| ||||||
| Robert W. Postma | Grant or award | Common Stock | 5,142 footnote F1 | $3.16 | $16K | |
| ||||||
| Michael Allen Jerman | Grant or award | Common Stock | 4,183 | $3.16 footnote F1 | $13K | |
| ||||||
| Ferdinand Groenewald - Officer | Grant or award | Common Stock | 10,775 | $0.00 | - | |
| Ferdinand Groenewald - Officer | Grant or award | Employee Stock Option (right to buy) | 4,000 | $0.00 | - | |
| Grant or award | Employee Stock Option (right to buy) | 13,676 | $0.00 | - | ||
| Michael Allen Jerman | Grant or award | Employee Stock Option (right to buy) | 10,000 | $0.00 | - | |
| Michael Allen Jerman | Grant or award | Employee Stock Option (right to buy) | 3,200 | $0.00 | - | |
| Robert W. Postma | Grant or award | Common Stock | 4,050 | $0.00 | - | |
| Robert W. Postma | Grant or award | Employee Stock Option (right to buy) | 6,400 | $0.00 | - | |
| Jaime Vieser | Grant or award | Common Stock | 3,400 | $0.00 | - | |
| Jaime Vieser | Grant or award | Employee Stock Option (right to buy) | 6,400 | $0.00 | - | |
| Grant or award | Employee Stock Option (right to buy) | 130,000 | $0.00 | - | ||
| Jaime Vieser | Open-market purchase | Series A-2 Convertible Preferred Stock | 250 | $4.49 | $1K | |
| Robert W. Postma | Grant or award | Common Stock | 20,804 | $2.92 | $61K | |
| Robert W. Postma | Open-market purchase | Series A-1 Convertible Preferred Stock | 500 | $2.76 | $1K | |
| Robert W. Postma | Open-market purchase | Series A-2 Convertible Preferred Stock | 600 | $4.49 | $3K | |
| Grant or award | Employee Stock Option (right to buy) | 10,904 | $0.00 | - | ||
TCRT insider trading FAQ
What is the latest insider trade for TCRT?
Alaunos Therapeutics, Inc. (TCRT) had 9 insider filings in the last 90 days, with the most recent on 2026-10-08. The full record for TCRT runs to 35 Form 4 filings, the earliest from 2025-03-29. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying TCRT stock?
No insider purchases of TCRT were filed in the last 90 days. 4 purchases are on record for this company.
How many insiders are selling TCRT stock?
No insider sales of TCRT were filed in the last 90 days.
Where can I see TCRT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects TCRT Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Holger Weis view on EDGAR
- - Jaime Vieser view on EDGAR
- - Robert W. Postma view on EDGAR
- - Michael Allen Jerman view on EDGAR
- - Holger Weis view on EDGAR
- - Michael Allen Jerman view on EDGAR
- - Holger Weis view on EDGAR
- - Robert W. Postma view on EDGAR
- - Jaime Vieser view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where TCRT's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow TCRT with a 7-day demo
- TCRT on your watchlist
- Every TCRT Form 4 filing on record
- Up to 3 months of TCRT price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive